Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial

Fig. 4

Association between the prevailing endotype at day 7 and 28-day outcome. Kaplan–Meier curves for the time of progression to severe respiratory failure and/or death by day 28 between patients treated with Standard-of-Care (SoC) and placebo versus Standard-of-Care (SoC) and anakinra and classified at day 7 into the coagulopathic endotype (upper panel left); the adaptive endotype (upper panel right); and the inflammopathic endotype (lower panel). Abbreviations: CI, confidence interval; HR, hazard ratio

Back to article page

Critical Care

ISSN: 1364-8535